ISRGINTUITIVE SURGICAL INC

Nasdaq intuitive.com


$ 415.76 $ -1.53 (-0.37 %)    

Monday, 10-Jun-2024 14:30:45 EDT
QQQ $ 463.08 $ 0.29 (0.06 %)
DIA $ 388.99 $ 0.64 (0.16 %)
SPY $ 534.47 $ 1.22 (0.23 %)
TLT $ 90.82 $ -0.21 (-0.23 %)
GLD $ 213.74 $ 0.65 (0.31 %)
$ 417.61
$ 417.29
$ 415.46 x 200
$ 0.00 x 0
$ 413.61 - $ 419.50
$ 254.85 - $ 420.57
1,199,562
na
150.55B
$ 1.37
$ 75.74
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-19-2024 03-31-2024 10-Q
2 01-31-2024 12-31-2023 10-K
3 10-20-2023 09-30-2023 10-Q
4 07-21-2023 06-30-2023 10-Q
5 04-20-2023 03-31-2023 10-Q
6 02-10-2023 12-31-2022 10-K
7 10-21-2022 09-30-2022 10-Q
8 07-22-2022 06-30-2022 10-Q
9 04-22-2022 03-31-2022 10-Q
10 02-03-2022 12-31-2021 10-K
11 10-20-2021 09-30-2021 10-Q
12 07-21-2021 06-30-2021 10-Q
13 04-21-2021 03-31-2021 10-Q
14 02-10-2021 12-31-2020 10-K
15 10-19-2020 09-30-2020 10-Q
16 07-23-2020 06-30-2020 10-Q
17 04-17-2020 03-31-2020 10-Q
18 02-07-2020 12-31-2019 10-K
19 10-18-2019 09-30-2019 10-Q
20 07-22-2019 06-30-2019 10-Q
21 04-19-2019 03-31-2019 10-Q
22 02-04-2019 12-31-2018 10-K
23 10-22-2018 09-30-2018 10-Q
24 07-20-2018 06-30-2018 10-Q
25 04-18-2018 03-31-2018 10-Q
26 02-02-2018 12-31-2017 10-K
27 10-20-2017 09-30-2017 10-Q
28 07-21-2017 06-30-2017 10-Q
29 04-19-2017 03-31-2017 10-Q
30 02-06-2017 12-31-2016 10-K
31 10-19-2016 09-30-2016 10-Q
32 07-20-2016 06-30-2016 10-Q
33 04-19-2016 03-31-2016 10-Q
34 02-02-2016 12-31-2015 10-K
35 10-21-2015 09-30-2015 10-Q
36 07-22-2015 06-30-2015 10-Q
37 04-22-2015 03-31-2015 10-Q
38 02-06-2015 12-31-2014 10-K
39 10-23-2014 09-30-2014 10-Q
40 07-24-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 intuitive-surgical-gets-fda-clearance-of-revised-da-vinci-xi-and-x-labeling-on-radical-prostatectomy-based-on-rwe-collected-from-2007-2014-that-demonstrates-overall-5--to-10-year-survival-following-robotic-assisted-radical-prostatectomy-is-similar-to-non-robotic-radical-prostatectomy

Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, ann...

 goldman-sachs-initiates-coverage-on-intuitive-surgical-with-buy-rating-announces-price-target-of-500

Goldman Sachs analyst David Roman initiates coverage on Intuitive Surgical (NASDAQ:ISRG) with a Buy rating and announces Pri...

 artificial-intelligence-etfs-have-they-beaten-the-market-in-2024

AI ETFs like BOTZ, AIQ, and ROBO have performed well in 2024 but couldn't beat the S&P 500, driven by tech giants like ...

 whats-going-on-with-nvidia-stock-today

NVIDIA collaborates on ORBIT-Surgical, a simulation framework for training surgical robots, ahead of its debut at ICRA.

 btig-maintains-buy-on-intuitive-surgical-raises-price-target-to-421

BTIG analyst Ryan Zimmerman maintains Intuitive Surgical (NASDAQ:ISRG) with a Buy and raises the price target from $412 to $...

 piper-sandler-maintains-overweight-on-intuitive-surgical-raises-price-target-to-435

Piper Sandler analyst Adam Maeder maintains Intuitive Surgical (NASDAQ:ISRG) with a Overweight and raises the price target f...

 jefferies-maintains-hold-on-intuitive-surgical-raises-price-target-to-375

Jefferies analyst David Windley maintains Intuitive Surgical (NASDAQ:ISRG) with a Hold and raises the price target from $365...

 baird-maintains-outperform-on-intuitive-surgical-lowers-price-target-to-436

Baird analyst Mike Polark maintains Intuitive Surgical (NASDAQ:ISRG) with a Outperform and lowers the price target from $440...

 wall-street-on-track-for-6th-day-of-losses-netflix-geopolitical-tensions-drag-futures-down-analyst-tells-why-next-2-weeks-are-pivotal

U.S. stocks appear headed for another losing day, potentially marking a sixth consecutive session in the red for Wall Street.